COVID-19 Presenting with Diabetic Ketoacidosis: A case report

Year 2022, , 123 - 125, 01.04.2022

İffet Beril Gökmen , Sidelya Ecem Yiğit , Yıldız Okuturlar , İftihar Köksal

https://doi.org/10.46310/tjim.1073576

Abstract

Diabetic ketoacidosis (DKA) is one of the most common fatal complications of diabetes and is often associated with severe underlying disease. The COVID-19 infection follows an intense course in patients with comorbidities such as diabetes. Herein we presented a case of diabetic ketoacidosis caused by COVID-19 infection.

Keywords

Covid-19, Diabetes Mellitus, Diabetic Ketoacidosis, Anion gap

References

• Pasquel FJ, Tsegka K, Wang H, Cardona S, Galindo RJ, Fayfman M, Davis G, Vellanki P, Migdal A, Gujral U, Narayan KMV, Umpierrez GE. Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: A retrospective, hospital-based cohort study. Diabetes Care. 2020 Feb;43(2):349-57. doi: 10.2337/dc19-1168.
• Pal R, Banerjee M, Yadav U, Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: a systematic review of literature. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1563-9. doi: 10.1016/j.dsx.2020.08.015.
• Vellanki P, Umpierrez GE. Diabetic ketoacidosis risk during the COVID-19 pandemic. Lancet Diabetes Endocrinol. 2021 Oct;9(10):643-4. doi: 10.1016/S2213-8587(21)00241-2.
• Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med. 2021 May 20;8:644095. doi: 10.3389/fcvm.2021.644095.
• Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, Jiang S, Demeter J, Bevacqua RJ, Chang CA, Whitener RL, Stalder AK, Zhu B, Chen H, Goltsev Y, Tzankov A, Nayak JV, Nolan GP, Matter MS, Andino R, Jackson PK. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021 Aug 3;33(8):1565-76.e5. doi: 10.1016/j.cmet.2021.05.013.